Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-22-000042

President and CEO sold 9,491 shares at $34.72 ($329,528)

From the SEC's structured data for this filing

Trades in this filing

Watts Ryan J. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-02-11 Sale : show line 1 in the form −9,491 $34.72 $329,528 2,129,648 I
Open-market sales · 9,491 sh · avg $34.72 · $329,528
Loading xslF345X03/wf-form4_164496949316138.xml…